THE INORGANIC NITRATE FOR EXERCISE IN HEART FAILURE (INIX-HF) TRIAL
THE INORGANIC NITRATE FOR EXERCISE IN HEART FAILURE (INIX-HF) TRIAL
批准号:
9754867
负责人:
ANDREW R COGGAN
金额:
$22.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-01 至 2021-07-31
关键词:
Activities of Daily LivingAdverse effectsAerobicAerobic ExerciseAffectBiological AvailabilityBloodCachexiaCardiacChronicClinicalClinical TrialsClinical trial protocol documentCross-Over StudiesDataData CollectionData Coordinating CenterDatabasesDiseaseDoseDouble-Blind MethodEFRACExerciseExtensorFailureFoundationsFunctional disorderFutureGoalsGrantHeart failureHourHypotensionImage AnalysisImpairmentInfrastructureIngestionKneeLaboratoriesLeadManualsMeasurementMeasuresMedical centerMetabolicMuscleMuscle ContractionMuscle functionMyocardiumNitratesNitric OxideNitritesOutcomeOxygen ConsumptionPathway interactionsPatientsPerformancePharmacological TreatmentPharmacologyPharmacy facilityPhase II Clinical TrialsPhysiciansPilot ProjectsPlacebosPlasmaProceduresProductionProtocols documentationPumpQuality of lifeRandomizedRandomized Clinical TrialsResearch DesignRouteSiteSkeletal MuscleSpecific qualifier valueSpeedStandardizationSumTestingTimeTorqueTreatment FailureWorkWritingalternative treatmentappropriate dosearmdesigndisabilityeffective therapyexercise capacityfollow-uphemodynamicsimprovedmembermortalitynovelnovel therapeuticsoperationoutcome forecastpower analysisprimary endpointquadriceps muscleresponseside effectskeletal abnormalitytargeted agenttreadmill
中文摘要
摘要
心力衰竭伴射血分数降低(HFrEF)在美国影响大约300万人,是一种致命和
病态的疾病。HFrEF损害患者的运动能力和日常生活活动能力。虽然
心脏泵血能力弱明显导致与HFrEF相关的慢性残疾,即骨骼异常
HFrEF患者的肌肉也是一个关键的衰弱因素。因此,骨骼肌是一个重要的目标
HFrEF的治疗。无机硝酸盐初步提高有氧运动能力和肌肉力量
HFrEF患者的研究。我们研究的总体目标(以及后续的随机临床试验
[RCT])的目的是确定无机硝酸盐是否提供了一种新的、安全有效的治疗方法来改善
由于HFrEF造成的残疾。本研究的具体目的是:1)确定无机硝酸盐的最佳用量
对于HFrEF患者;2)确定最佳主要终点(有氧能力或肌肉力量)和
RCT将需要的患者数量;以及3)设置基础设施和所需手册
跨多个医疗中心的RCT协议的标准化性能。对于目标1,
10 mmo3和20 mmo3硝酸钾与安慰剂比较对血流动力学、血液硝酸盐和亚硝酸盐水平及呼吸的影响
将对NO进行测量,并记录任何副作用。在目标2中,对2wk硝酸钾进行了一项小型II期临床试验
在一项随机、安慰剂对照、非交叉设计研究中,治疗(剂量由Aim 1确定)将是
已执行。这一目标的终点将是有氧能力(峰值耗氧量-VO2峰值),
在跑步机运动中使用代谢车测量,并使用
一台生物索引机。在目标3中,将建造区域工作队所需的所有基础设施。红帽™
将创建用于从所有RCT站点输入、存储和导出数据的数据库。所有核心(数据协调
中心、影像分析核心、实验室核心、运动分析核心、药房核心)将用于RCT
将编写已建立的操作手册和手册。寻找一种新的、安全有效的
帮助数百万患者战胜HFrEF残疾的治疗是巨大的。
英文摘要
ABSTRACT
Heart failure with reduced ejection fraction (HFrEF) affects roughly 3 million in the U.S. and is a mortal and
morbid disease. HFrEF impairs a patient's ability to exercise and perform activities of daily living. Although
weak cardiac pumping ability clearly contributes to chronic disability associated with HFrEF, abnormal skeletal
muscle in patients with HFrEF is also a key debilitating factor. Skeletal muscle is therefore a vital target for
treatment of HFrEF. Inorganic nitrate enhances aerobic exercise capacity and muscle power in preliminary
studies of patients with HFrEF. The overarching aim of our study (and the follow-up randomized clinical trial
[RCT]) is to determine whether inorganic nitrate offers a new, safe and effective treatment for ameliorating the
disability due to HFrEF. The Specific Aims of this study are 1) to determine the best dose of inorganic nitrate
for patients with HFrEF; 2) to determine the best primary endpoint (aerobic capacity or muscle power) and the
number of patients that will be needed for the RCT; and 3) to set up the infrastructure and manuals needed for
standardized performance of the RCT protocols across multiple medical centers. For Aim 1, the effects of
10mmol and 20mmol of KNO3 vs. placebo on hemodynamics, and blood levels of nitrate and nitrite and breath
NO will be measured and any side effects noted. In Aim 2, a small, phase II clinical trial of 2 wk of KNO3
treatment (dose determined by Aim 1) in a randomized, placebo-controlled, non-crossover design study will be
performed. The endpoints of this aim will be aerobic capacity (peak oxygen consumption – VO2peak),
measured during treadmill exercise using a metabolic cart and peak quadriceps muscle power measured using
a Biodex machine. In Aim 3, all of the infrastructure needed for the RCT will be constructed. A RedCAP™
database for data entry, storage, and export from all RCT sites will be created. All Cores (Data Coordinating
Center, Imaging Analysis Core, Laboratory Core, Exercise Analysis Core, Pharmacy Core) for the RCT will be
established and Manuals of Operation will be written. The potential impact of finding a new, safe and effective
treatment that helps millions of patients beat the disability of HFrEF is enormous.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
[Reply to Notarius].
[回复公证人]。
DOI:
10.1016/j.cardfail.2019.02.001
发表时间:
2019
期刊:
Journal of cardiac failure
影响因子:
6
作者:
[Coggan,AndrewR, Peterson,LindaR]
通讯作者:
Peterson,LindaR
The Inorganic Nitrate and eXercise performance in Heart Failure (iNIX-HF): - a phase II clinical trial
-
批准号:10731565
-
项目类别:
-
资助金额:$73.72万
-
财政年份:2022
-
负责人:ANDREW R COGGAN
-
依托单位:
The Inorganic Nitrate and eXercise performance in Heart Failure (iNIX-HF): - a phase II clinical trial
-
批准号:10449833
-
项目类别:
-
资助金额:$80.38万
-
财政年份:2022
-
负责人:ANDREW R COGGAN
-
依托单位:
Dietary Nitrate and Muscle Power with Aging
-
批准号:9764237
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2018
-
负责人:ANDREW R COGGAN
-
依托单位:
THE INORGANIC NITRATE FOR EXERCISE IN HEART FAILURE (INIX-HF) TRIAL
-
批准号:9374210
-
项目类别:
-
资助金额:$23.75万
-
财政年份:2017
-
负责人:ANDREW R COGGAN
-
依托单位:
EFFECT OF GENDER ON SUBSTRATE UTILIZATION DURING SUBMAXIMAL EXERCISE
-
批准号:6115180
-
项目类别:
-
资助金额:$3.42万
-
财政年份:1998
-
负责人:ANDREW R COGGAN
-
依托单位:
AGING AND SKELETAL MUSCLE FATTY ACID METABOLISM
-
批准号:2387920
-
项目类别:
-
资助金额:$14.26万
-
财政年份:1997
-
负责人:ANDREW R COGGAN
-
依托单位:
AGING AND SKELETAL MUSCLE FATTY ACID METABOLISM
-
批准号:2769437
-
项目类别:
-
资助金额:$12.25万
-
财政年份:1997
-
负责人:ANDREW R COGGAN
-
依托单位:
AGING AND SKELETAL MUSCLE FATTY ACID METABOLISM
-
批准号:2832413
-
项目类别:
-
资助金额:$12.7万
-
财政年份:1997
-
负责人:ANDREW R COGGAN
-
依托单位:
EFFECT OF GENDER ON SUBSTRATE UTILIZATION DURING SUBMAXIMAL EXERCISE
-
批准号:6276415
-
项目类别:
-
资助金额:$2.69万
-
财政年份:1997
-
负责人:ANDREW R COGGAN
-
依托单位:
FREE FATTY ACID AVAILABILITY ON PLASMA GLUCOSE KINETICS DURING EXERCISE
-
批准号:3882878
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ANDREW R COGGAN
-
依托单位:
EFFECT OF GENDER ON SUBSTRATE UTILIZATION DURING SUBMAXIMAL EXERCISE
-
批准号:6305283
-
项目类别:
-
资助金额:$3.42万
-
财政年份:--
-
负责人:ANDREW R COGGAN
-
依托单位:
海外基金